Search Results | Blood | American Society of Hematology

1-20 of 94

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Geno-Clinical Model for the Diagnosis of Bone Marrow Myeloid Neoplasms

Blood (2019) 134 (Supplement_1): 4238.

DOI: https://doi.org/10.1182/blood-2019-126967

Published: 2019

Journal Articles

Clinical and Molecular Heterogeneity of Moderate Aplastic Anemia

Bhumika J. Patel, MD, Shimoli Vipul Barot, MD, Teodora Kuzmanovic, BA, Bartlomiej P. Przychodzen, Cassandra M. Hirsch, Hassan Awada, MD, Metis Hasipek, PhD, Swapna Thota, MD, Tomas Radivoyevitch, PhD, Anjali S. Advani, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD MS, Hetty E. Carraway, MD MBA, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 2590.

DOI: https://doi.org/10.1182/blood-2018-99-119852

Published: 2018

Journal Articles

Next-Generation Sequencing Reveals a T Cell Receptor Signature Characteristic of Patients with Aplastic Anemia

Sofie Lundgren, BMed, Jani Huuhtanen, BMed, Mikko A Keränen, MD PhD, Cassandra M. Hirsch, Emmi Jokinen, MSc, Markus Heinonen, PhD, Paula Savola, MD, Tiina Kelkka, PhD, Freja Ebeling, MD PhD, Jaroslaw P. Maciejewski, Eva Hellström-Lindberg, MD PhD, Harri Lähdesmäki, PhD, Satu Mustjoki, MDPhD

Blood (2018) 132 (Supplement 1): 537.

DOI: https://doi.org/10.1182/blood-2018-99-117811

Published: 2018

Journal Articles

Genetic Predisposition to Therapy-Related Myeloid Neoplasm By Rare, Deleterious Germline Variants in DNA Repair Pathway and Myeloid Driver Genes

Blood (2018) 132 (Supplement 1): 1802.

DOI: https://doi.org/10.1182/blood-2018-99-117815

Published: 2018

Journal Articles

Biallelic TET2 Inactivation in Myeloid Neoplasia: From Clonal Hierarchy to Clinical Phenotypes

Blood (2018) 132 (Supplement 1): 1805.

DOI: https://doi.org/10.1182/blood-2018-99-115154

Published: 2018

Journal Articles

Geno-Clinical Model to Aid in the Diagnosis of Myelodysplastic Syndrome (MDS) Versus Chronic Myelomonocytic Leukemia (CMML)

Blood (2018) 132 (Supplement 1): 1813.

DOI: https://doi.org/10.1182/blood-2018-99-115180

Published: 2018

Journal Articles

Genotype-Resultant Morphology of Myelodysplastic Syndromes (MDS)

Abhinav Goyal, Inom Mirzaev, Mohammad Fahad B. Asad, Hassan Awada, MD, Cassandra M. Hirsch, Hideki Makishima, MD PhD, Kenichi Yoshida, MD PhD, Bartlomiej P. Przychodzen, Aziz Nazha, Sudipto Mukherjee, MD PhD MPH, Mikkael A. Sekeres, MD MS, Seishi Ogawa, MD PhD, Tomas Radivoyevitch, PhD, Jacob Scott, MD, Jaroslaw P. Maciejewski, Yasunobu Nagata

Blood (2018) 132 (Supplement 1): 1824.

DOI: https://doi.org/10.1182/blood-2018-99-119345

Published: 2018

Journal Articles

A Personalized Prediction Model to Risk Stratify Patients with Myelodysplastic Syndromes

Blood (2018) 132 (Supplement 1): 793.

DOI: https://doi.org/10.1182/blood-2018-99-114774

Published: 2018

Journal Articles

Polyclonal Immune Response in T-LGL Leads to Clonal Expansions Preceding Occurrence of STAT3 Mutations Further Solidifying Clonal Dominance

Cassandra M. Hirsch, Michael Clemente, MS, Peter Chomczynski, Bartlomiej P. Przychodzen, Yasunobu Nagata, Vera Adema, PhD, Louis Williams, MD MBA, Valeria Visconte, PhD, Alan Lichtin, MD, Satu Mustjoki, MDPhD, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 516.

DOI: https://doi.org/10.1182/blood-2018-99-116307

Published: 2018

Journal Articles

Molecular Spectrum of CSF3R variants Correlate with Specific Myeloid Malignancies and Secondary Mutations

Vera Adema, PhD, Cassandra M. Hirsch, Bartlomiej Przychodzen, Yasunobu Nagata, Tomas Radivoyevitch, Thomas Laframboise, PhD, Amy C Graham, BS, MS, Louis Williams, MD MBA, Hassan Awada, MD, Aziz Nazha, Hetty E. Carraway, MD MBA, Valeria Santini, Hrishikesh M Mehta, PhD, Francesc Sole, PhD, Mikkael A. Sekeres, MD MS, Valeria Visconte, PhD, Rabi Hanna, MD, Seth J. Corey, MD, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 4389.

DOI: https://doi.org/10.1182/blood-2018-99-116554

Published: 2018

Journal Articles

Lessons from Nature: A Novel Class of TET Inhibitors for TET2 Mutant Associated Diseases

Yihong Guan, Anand D. Tiwari, PhD, Metis Hasipek, PhD, Dale Grabowski, BS, Yvonne Parker, Cassandra M. Hirsch, Amy C Graham, BS, MS, Yasunobu Nagata, Bartlomiej P. Przychodzen, Aziz Nazha, Daniel Lindner, MD PhD, Tomas Radivoyevitch, PhD, James G Phillips, PhD, Jaroslaw P. Maciejewski, Babal K. Jha

Blood (2018) 132 (Supplement 1): 4345.

DOI: https://doi.org/10.1182/blood-2018-99-117186

Published: 2018

Journal Articles

Modulation of TET2 Activity By Ascorbic Acid and Factors Affecting Lysine Acetylation

Blood (2018) 132 (Supplement 1): 4346.

DOI: https://doi.org/10.1182/blood-2018-99-119712

Published: 2018

Journal Articles

Opposing Pathogenesis of Germline SAMD9/SAMD9L Variants in Adult Myelodysplastic Syndrome (MDS)

Blood (2018) 132 (Supplement 1): 4351.

DOI: https://doi.org/10.1182/blood-2018-99-119896

Published: 2018

Journal Articles

BRCA1 & BRCA2 Germline Variants Are Enriched in MDS/AML and Portend Higher Average Mutational Burden

Louis Williams, MD MBA, Teodora Kuzmanovic, BA, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Yogenthiran Saunthararajah, MD, Hassan Awada, MD, Vera Adema, PhD, Amy C Graham, BS, MS, Tomas Radivoyevitch, PhD, Hetty E. Carraway, MD MBA, Aziz Nazha, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 4352.

DOI: https://doi.org/10.1182/blood-2018-99-116802

Published: 2018

Journal Articles

Distinct Implications of TP53 Hits for Patients with Treatment-Related MDS and AML

Teodora Kuzmanovic, Bhumika J. Patel, MD, Yasunobu Nagata, Hassan Awada, MD, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Srinivasa Reddy Sanikommu, MD, Louis Williams, MD MBA, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aziz Nazha, Aaron T. Gerds, MD MS, Tomas Radivoyevitch, PhD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 4353.

DOI: https://doi.org/10.1182/blood-2018-99-120059

Published: 2018

Journal Articles

Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia

Rachel Hu, MD, Aziz Nazha, Xuefei Jia, MS, Brian P. Hobbs, PhD, Hetty E. Carraway, MD MBA, Sudipto Mukherjee, MDPhDMPH, Aaron T. Gerds, MDMS, Anjali S. Advani, MD, Yasunobu Nagata, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Babal K. Jha, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 1527.

DOI: https://doi.org/10.1182/blood-2018-99-114273

Published: 2018

Journal Articles

Genomic Biomarkers Predict Response/Resistance to Lenalidomide in Non-Del(5q) Myelodysplastic Syndromes

Yazan F. Madanat, MD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MDPhDMPH, Cassandra M. Hirsch, Yihong Guan, Yasunobu Nagata, Vera Adema, PhD, Metis Hasipek, PhD, Aaron T. Gerds, MDMS, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Bartlomiej P. Przychodzen, Valeria Santini, Jaroslaw P. Maciejewski, Babal K. Jha, Aziz Nazha

Blood (2018) 132 (Supplement 1): 1797.

DOI: https://doi.org/10.1182/blood-2018-99-114681

Published: 2018

Journal Articles

Clinical Outcomes for Patients with Myeloid Malignancies Harboring IDH1/2 mutations after Intensive Chemotherapy

Swapna Thota, MD, Bhumika J. Patel, MD, Hetty E. Carraway, MD MBA, Elizabeth A. Griffiths, MD, Amanda Przespolewski, DO, James E. Thompson, MD, Teodora Kuzmanovic, Aziz Nazha, Shimoli Vipul Barot, MD, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Sudipto Mukherjee, MDPhDMPH, Meghan Scully, NP, Aaron T. Gerds, MDMS, Anjali S. Advani, MD, Mikkael A. Sekeres, MD MS, Manja Meggendorfer, PhD, Eunice S. Wang, MD, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 1389.

DOI: https://doi.org/10.1182/blood-2018-99-119306

Published: 2018

Journal Articles

Selective Pharmacologic Inhibition of Paroxysmal Nocturnal Hemoglobinuria Clones

Amy C Graham, BS, MS, Alexey Efanov, PhD, Bartlomiej P. Przychodzen, Cassandra M. Hirsch, Vera Adema, PhD, Valeria Visconte, PhD, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 1303.

DOI: https://doi.org/10.1182/blood-2018-99-114973

Published: 2018

Journal Articles

Invariant Patterns of Clonal Succession Determines Specific Phenotypic and Clinical Features of Myelodysplastic Syndromes (MDS)

Blood (2018) 132 (Supplement 1): 104.

DOI: https://doi.org/10.1182/blood-2018-99-118861

Published: 2018

2 3 4 5

NARROW

Geno-Clinical Model for the Diagnosis of Bone Marrow Myeloid Neoplasms

Clinical and Molecular Heterogeneity of Moderate Aplastic Anemia

Next-Generation Sequencing Reveals a T Cell Receptor Signature Characteristic of Patients with Aplastic Anemia

Genetic Predisposition to Therapy-Related Myeloid Neoplasm By Rare, Deleterious Germline Variants in DNA Repair Pathway and Myeloid Driver Genes

Biallelic TET2 Inactivation in Myeloid Neoplasia: From Clonal Hierarchy to Clinical Phenotypes

Geno-Clinical Model to Aid in the Diagnosis of Myelodysplastic Syndrome (MDS) Versus Chronic Myelomonocytic Leukemia (CMML)

Genotype-Resultant Morphology of Myelodysplastic Syndromes (MDS)

A Personalized Prediction Model to Risk Stratify Patients with Myelodysplastic Syndromes

Polyclonal Immune Response in T-LGL Leads to Clonal Expansions Preceding Occurrence of STAT3 Mutations Further Solidifying Clonal Dominance

Molecular Spectrum of CSF3R variants Correlate with Specific Myeloid Malignancies and Secondary Mutations

Lessons from Nature: A Novel Class of TET Inhibitors for TET2 Mutant Associated Diseases

Modulation of TET2 Activity By Ascorbic Acid and Factors Affecting Lysine Acetylation

Opposing Pathogenesis of Germline SAMD9/SAMD9L Variants in Adult Myelodysplastic Syndrome (MDS)

BRCA1 & BRCA2 Germline Variants Are Enriched in MDS/AML and Portend Higher Average Mutational Burden

Distinct Implications of TP53 Hits for Patients with Treatment-Related MDS and AML

Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia

Genomic Biomarkers Predict Response/Resistance to Lenalidomide in Non-Del(5q) Myelodysplastic Syndromes

Clinical Outcomes for Patients with Myeloid Malignancies Harboring IDH1/2 mutations after Intensive Chemotherapy

Selective Pharmacologic Inhibition of Paroxysmal Nocturnal Hemoglobinuria Clones

Invariant Patterns of Clonal Succession Determines Specific Phenotypic and Clinical Features of Myelodysplastic Syndromes (MDS)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only